Landmark multi-year patent battle in China ends with foreign biotech innovator coming out on top
In what it hailed as a “landmark” biotech patent validity case, Danish company Novozymes has won out in a six year patent fight with major Chinese competitors following a judgment from the Supreme People’s Court. The result is important because…
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.